Cargando…
Chemotherapy-induced fatal hepatitis B virus reactivation in a small-cell lung cancer patient
Hepatitis B virus (HBV) reactivation during chemotherapy is a major concern and is widely reported, particularly in association with hematological malignancies and lymphomas. While lung cancer ranks first in incidence and mortality worldwide, HBV reactivation has been largely overlooked in this dise...
Autores principales: | Qin, Lei, Wang, Fang, Zou, Bing-Wen, Ding, Zhen-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038378/ https://www.ncbi.nlm.nih.gov/pubmed/27699030 http://dx.doi.org/10.3892/mco.2016.989 |
Ejemplares similares
-
Fatal Hepatitis C after Chemotherapy in a Patient with Malignant Lymphoma: Possible Reactivation of Seronegative Occult Hepatitis C Virus Infection Due to Chemotherapy
por: Miyashita, Kaname, et al.
Publicado: (2020) -
Fatal outcome of SARS in a patient with reactivation of chronic hepatitis B
por: Hui, Alex Y., et al.
Publicado: (2003) -
Hepatitis B virus reactivation and hepatitis in diffuse large B-cell lymphoma patients with resolved hepatitis B receiving rituximab-containing chemotherapy: risk factors and survival
por: Chen, Kai-Lin, et al.
Publicado: (2015) -
Screening and prevention of hepatitis C virus reactivation during chemotherapy
por: Li, Yuan-Rung, et al.
Publicado: (2021) -
Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis
por: Wu, Yu-tuan, et al.
Publicado: (2017)